Strategies for the treatment of intraocular inflammatory disease.
Nussenblatt
R B
RB
Laboratory of Immunology, National Eye Institute, NIH, Bethesda, Maryland, USA.
Schiffman
R
R
Fortin
E
E
Robinson
M
M
Smith
J
J
Rizzo
L
L
Csaky
K
K
Gery
I
I
Waldmann
T
T
Whitcup
S M
SM
D000818:Animals; D019393:Arrestin / Q000627:therapeutic use; D016207:Cytokines / Q000096:biosynthesis / Q000235:genetics; D004195:Disease Models, Animal; D005136:Eye Proteins / Q000627:therapeutic use; D006801:Humans; D007108:Immune Tolerance; D007167:Immunotherapy / Q000379:methods; D051379:Mice; D012177:Retinol-Binding Proteins / Q000627:therapeutic use; D018418:Th2 Cells / Q000276:immunology; D014605:Uveitis / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D000099214:Retinol-Binding Proteins, Interstitial
D019393:Arrestin; D016207:Cytokines; D005136:Eye Proteins; D012177:Retinol-Binding Proteins; D000099214:Retinol-Binding Proteins, Interstitial